Literature DB >> 18983973

E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression.

Liying Wang1, Zengxia Li, Can Wang, Yong Yang, Lidong Sun, Wantong Yao, Xiumei Cai, Guoqiang Wu, Feng Zhou, Xiliang Zha.   

Abstract

E-cadherin, a well-characterized cell-cell adhesion molecule, executes multifunction roles on cell behaviors. However, its effect on chemo-resistance remains controversial. In this study, we found that E-cadherin positive breast cell lines were less sensitive to staurosporine compared to E-cadherin negative ones. Next, we substantiated that the expression of E-cadherin in MDA-MB-435 cells could partly counteract the cytotoxic effect induced by staurosporine through a series of apoptosis assay. The resistance of E-cadherin over-expressing cells to staurosporine may due to the up-regulation of Bcl-2/Bax ratio. When E-cadherin interference plasmids were transfected into MCF-7 cells, Bcl-2 expression was down-regulated. Moreover, perturbation of E-cadherin function by blocking the cell-cell contact resulted in decreased cellular levels of Bcl-2 protein expression. All these results demonstrated the chemo-resistance function of E-cadherin in the condition of staurosporine treatment, therefore, might contribute effective therapeutic strategies in breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983973     DOI: 10.1016/j.abb.2008.10.021

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance.

Authors:  Yvonne Chao; Qian Wu; Christopher Shepard; Alan Wells
Journal:  Clin Exp Metastasis       Date:  2011-10-02       Impact factor: 5.150

2.  Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

Authors:  Yvonne L Chao; Christopher R Shepard; Alan Wells
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

3.  N-cadherin mediates neuronal cell survival through Bim down-regulation.

Authors:  Elise C Lelièvre; Charlotte Plestant; Cécile Boscher; Emeline Wolff; René-Marc Mège; Hélène Birbes
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

4.  Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma.

Authors:  Jinquan Cai
Journal:  Exp Ther Med       Date:  2013-10-14       Impact factor: 2.447

Review 5.  Killing me softly--future challenges in apoptosis research.

Authors:  Mike-Andrew Westhoff; Oliver Brühl; Lisa Nonnenmacher; Georg Karpel-Massler; Klaus-Michael Debatin
Journal:  Int J Mol Sci       Date:  2014-03-03       Impact factor: 5.923

6.  Evaluation of E-cadherin Expression in Gastric Cancer and Its Correlation with Clinicopathologic Parameters.

Authors:  Zhila Torabizadeh; Anahita Nosrati; Seyedeh Neda Sajadi Saravi; Jamshid Yazdani Charati; Ghasem Janbabai
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

7.  Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells.

Authors:  Ming-Liang Zhu; Pei-Min Zhang; Min Jiang; Shu-Wen Yu; Lu Wang
Journal:  BMC Complement Med Ther       Date:  2020-07-06

8.  Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro-In Silico Model.

Authors:  José Eduardo Vargas; Renato Puga; Guido Lenz; Cristiano Trindade; Eduardo Filippi-Chiela
Journal:  Oxid Med Cell Longev       Date:  2020-11-01       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.